Item 16. Form 10-K Summary

5K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Henry Schein, Inc.

	By: /s/ STANLEY M. BERGMAN
	Stanley M. Bergman
	Chairman and Chief Executive Officer
	February 15, 2022

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

Signature	Capacity	Date

/s/ STANLEY M. BERGMAN	Chairman, Chief Executive Officer	February 15, 2022
Stanley M. Bergman	and Director (principal executive officer)

/s/ STEVEN PALADINO	Executive Vice President, Chief Financial Officer	February 15, 2022
Steven Paladino	and Director (principal financial and accounting officer)

/s/ JAMES P. BRESLAWSKI	Vice Chairman, President and Director	February 15, 2022
James P. Breslawski

/s/ GERALD A. BENJAMIN	Director	February 15, 2022
Gerald A. Benjamin

/s/ MARK E. MLOTEK	Director	February 15, 2022
Mark E. Mlotek

/s/ MOHAMAD ALI	Director	February 15, 2022
Mohamad Ali

/s/ BARRY J. ALPERIN	Director	February 15, 2022
Barry J. Alperin

/s/ DEBORAH DERBY	Director	February 15, 2022
Deborah Derby

/s/ JOSEPH L. HERRING	Director	February 15, 2022
Joseph L. Herring

/s/ KURT P. KUEHN	Director	February 15, 2022
Kurt P. Kuehn

/s/ PHILIP A. LASKAWY	Director	February 15, 2022
Philip A. Laskawy

/s/ ANNE H. MARGULIES	Director	February 15, 2022
Anne H. Margulies

/s/ CAROL RAPHAEL	Director	February 15, 2022
Carol Raphael

/s/ E. DIANNE REKOW	Director	February 15, 2022
E. Dianne Rekow, DDS, Ph.D.

/s/ SCOTT SEROTA	Director	February 15, 2022
Scott Serota

/s/ BRADLEY T. SHEARES, PH. D.	Director	February 15, 2022
Bradley T. Sheares, Ph. D.

/s/ REED V. TUCKSON, M.D., FACP	Director	February 15, 2022
Reed V. Tuckson, M.D., FACP

Schedule II

Valuation and Qualifying Accounts

(in thousands)

					Additions (Reductions)
					Charged		Charged
			Balance at		(credited) to		(credited) to				Balance at
			beginning of		statement of		other				end of
Description			period		income (1)		accounts (2)		Deductions (3)		period

Year ended December 25, 2021:
	Allowance for doubtful accounts
		and other	$	88,030	$	(7,748)	$	(4,624)	$	(8,490)	$	67,168

Year ended December 26, 2020:
	Allowance for doubtful accounts
		and other	$	60,002	$	35,137	$	730	$	(7,839)	$	88,030

Year ended December 28, 2019:
	Allowance for doubtful accounts
		and other	$	53,121	$	12,612	$	134	$	(5,865)	$	60,002

(1)	Represents amounts charged (credited) to bad debt expense.

(2)	Amounts charged (credited) to other accounts primarily relate to provision for late fees and the impact of foreign currency exchange rates and the adoption of ASU No. 2016-13 effective December 29, 2019.

(3)	Deductions primarily consist of fully reserved accounts receivable that have been written off.

Previous: Item 15. Exhibits, Financial Statement Schedules